Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Hum Mol Genet ; 20(9): 1701-11, 2011 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-21300694

RESUMEN

Spinal muscular atrophy (SMA), an inherited disease of motor neuron dysfunction, results from insufficient levels of the survival motor neuron (SMN) protein. Movement of the SMN protein as granules within cultured axons suggests that the pathogenesis of SMA may involve defects in neuronal transport, yet the nature of axon transport vesicles remains enigmatic. Here we show that SMN directly binds to the α-subunit of the coat protein I (COPI) vesicle coat protein. The α-COP protein co-immunoprecipitates with SMN, small nuclear ribonucleoprotein-associated assembly factors and ß-actin mRNA. Although typically Golgi associated, in neuronal cells α-COP localizes to lamellipodia and growth cones and moves within the axon, with a subset of these granules traveling together with SMN. Depletion of α-COP resulted in mislocalization of SMN and actin at the leading edge at the lamellipodia. We propose that neurons utilize the Golgi-associated COPI vesicle to deliver cargoes necessary for motor neuron integrity and function.


Asunto(s)
Axones/metabolismo , Proteína Coat de Complejo I/metabolismo , Neuronas Motoras/metabolismo , Atrofia Muscular Espinal/metabolismo , Vesículas Transportadoras/metabolismo , Animales , Línea Celular , Supervivencia Celular , Proteína Coat de Complejo I/genética , Modelos Animales de Enfermedad , Humanos , Ratones , Neuronas Motoras/citología , Atrofia Muscular Espinal/genética , Unión Proteica , Transporte de Proteínas , Proteína 1 para la Supervivencia de la Neurona Motora/genética , Proteína 1 para la Supervivencia de la Neurona Motora/metabolismo , Vesículas Transportadoras/genética
2.
J Neurosci ; 29(34): 10488-98, 2009 Aug 26.
Artículo en Inglés | MEDLINE | ID: mdl-19710302

RESUMEN

Macropinocytosis is a type of poorly characterized fluid-phase endocytosis that results in formation of relatively large vesicles. We report that Sonic hedgehog (Shh) protein induces macropinocytosis in the axons through activation of a noncanonical signaling pathway, including Rho GTPase and nonmuscle myosin II. Macropinocytosis induced by Shh is independent of clathrin-mediated endocytosis but dependent on dynamin, myosin II, and Rho GTPase activities. Inhibitors of macropinocytosis also abolished the negative effects of Shh on axonal growth, including growth cone collapse and chemorepulsive axon turning but not turning per se. Conversely, activation of myosin II or treatment of phorbol ester induces macropinocytosis in the axons and elicits growth cone collapse and repulsive axon turning. Furthermore, macropinocytosis is also induced by ephrin-A2, and inhibition of dynamin abolished repulsive axon turning induced by ephrin-A2. Macropinocytosis can be induced ex vivo by high Shh, correlating with axon retraction. These results demonstrate that macropinocytosis-mediated membrane trafficking is an important cellular mechanism involved in axon chemorepulsion induced by negative guidance factors.


Asunto(s)
Axones/fisiología , Conos de Crecimiento/fisiología , Pinocitosis/fisiología , Animales , Axones/efectos de los fármacos , Células Cultivadas , Embrión de Pollo , Dextranos/metabolismo , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Inhibidores Enzimáticos/farmacología , Proteínas Fluorescentes Verdes/genética , Conos de Crecimiento/efectos de los fármacos , Proteínas Hedgehog/farmacología , Técnicas In Vitro , Miosina Tipo II/metabolismo , Pinocitosis/efectos de los fármacos , Células Ganglionares de la Retina/citología , Acetato de Tetradecanoilforbol/farmacología , Factores de Tiempo , Transfección , Transferrina/metabolismo , Alcaloides de Veratrum/farmacología , Proteínas de Unión al GTP rho/metabolismo
3.
BMC Cell Biol ; 8: 13, 2007 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-17391516

RESUMEN

BACKGROUND: The NCOA7 gene product is an estrogen receptor associated protein that is highly similar to the human OXR1 gene product, which functions in oxidation resistance. OXR genes are conserved among all sequenced eukaryotes from yeast to humans. In this study we examine if NCOA7 has an oxidation resistance function similar to that demonstrated for OXR1. We also examine NCOA7 expression in response to oxidative stress and its subcellular localization in human cells, comparing these properties with those of OXR1. RESULTS: We find that NCOA7, like OXR1 can suppress the oxidative mutator phenotype when expressed in an E. coli strain that exhibits an oxidation specific mutator phenotype. Moreover, NCOA7's oxidation resistance function requires expression of only its carboxyl-terminal domain and is similar in this regard to OXR1. We find that, in human cells, NCOA7 is constitutively expressed and is not induced by oxidative stress and appears to localize to the nucleus following estradiol stimulation. These properties of NCOA7 are in striking contrast to those of OXR1, which is induced by oxidative stress, localizes to mitochondria, and appears to be excluded, or largely absent from nuclei. CONCLUSION: NCOA7 most likely arose from duplication. Like its homologue, OXR1, it is capable of reducing the DNA damaging effects of reactive oxygen species when expressed in bacteria, indicating the protein has an activity that can contribute to oxidation resistance. Unlike OXR1, it appears to localize to nuclei and interacts with the estrogen receptor. This raises the possibility that NCOA7 encodes the nuclear counterpart of the mitochondrial OXR1 protein and in mammalian cells it may reduce the oxidative by-products of estrogen metabolite-mediated DNA damage.


Asunto(s)
Péptidos y Proteínas de Señalización Intracelular/fisiología , Estrés Oxidativo , Proteínas/química , Núcleo Celular/metabolismo , Secuencia Conservada , Daño del ADN , Escherichia coli , Células Eucariotas , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Peróxido de Hidrógeno/farmacología , Péptidos y Proteínas de Señalización Intracelular/química , Péptidos y Proteínas de Señalización Intracelular/genética , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Proteínas Mitocondriales , Familia de Multigenes , Coactivadores de Receptor Nuclear , Estructura Terciaria de Proteína/fisiología , Proteínas/genética , Proteínas/fisiología , Células Tumorales Cultivadas
4.
J Neurosci ; 25(13): 3432-41, 2005 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-15800198

RESUMEN

The stereotypical projection of retinal ganglion cell (RGC) axons to the optic disc has served as a good model system for studying axon guidance. By both in vitro and in vivo experiments, we show that a secreted molecule, Sonic hedgehog (Shh), may play a critical role in the process. It is expressed in a dynamic pattern in the ganglion cell layer with a relatively higher expression in the center of the retina. Through gel culture and stripe assays, we show that Shh has a dual effect on RGC axonal growth, acting as a positive factor at low concentrations and a negative factor at high concentrations. Results from time-lapse video microscopic and stripe assay experiments further suggest that the effects of Shh on axons are not likely attributable to indirect transcriptional regulation by Shh. Overexpression of Shh protein or inhibition of Shh function inside the retina resulted in a complete loss of centrally directed projection of RGC axons, suggesting that precise regulation of Shh level inside the retina is critical for the projection of RGC axons to the optic disc.


Asunto(s)
Axones/fisiología , Retina/citología , Células Ganglionares de la Retina/citología , Transactivadores/fisiología , Factores de Edad , Animales , Axones/efectos de los fármacos , Células Cultivadas , Embrión de Pollo , Técnicas de Cocultivo/métodos , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Técnica del Anticuerpo Fluorescente/métodos , Regulación del Desarrollo de la Expresión Génica/fisiología , Proteínas Fluorescentes Verdes/metabolismo , Conos de Crecimiento/efectos de los fármacos , Conos de Crecimiento/fisiología , Proteínas Hedgehog , Hibridación in Situ/métodos , Inhibición Neural/efectos de los fármacos , Inhibición Neural/fisiología , Disco Óptico/citología , Disco Óptico/metabolismo , Técnicas de Cultivo de Órganos/métodos , ARN Mensajero/metabolismo , Proteínas Recombinantes/metabolismo , Retina/metabolismo , Células Ganglionares de la Retina/efectos de los fármacos , Factores de Tiempo , Transactivadores/genética , Alcaloides de Veratrum/farmacología
5.
Neuron ; 82(2): 334-49, 2014 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-24656932

RESUMEN

The ocular motility disorder "Congenital fibrosis of the extraocular muscles type 1" (CFEOM1) results from heterozygous mutations altering the motor and third coiled-coil stalk of the anterograde kinesin, KIF21A. We demonstrate that Kif21a knockin mice harboring the most common human mutation develop CFEOM. The developing axons of the oculomotor nerve's superior division stall in the proximal nerve; the growth cones enlarge, extend excessive filopodia, and assume random trajectories. Inferior division axons reach the orbit but branch ectopically. We establish a gain-of-function mechanism and find that human motor or stalk mutations attenuate Kif21a autoinhibition, providing in vivo evidence for mammalian kinesin autoregulation. We identify Map1b as a Kif21a-interacting protein and report that Map1b⁻/⁻ mice develop CFEOM. The interaction between Kif21a and Map1b is likely to play a critical role in the pathogenesis of CFEOM1 and highlights a selective vulnerability of the developing oculomotor nerve to perturbations of the axon cytoskeleton.


Asunto(s)
Axones/patología , Enfermedades Hereditarias del Ojo/genética , Fibrosis/genética , Cinesinas/genética , Cinesinas/metabolismo , Mutación/genética , Trastornos de la Motilidad Ocular/genética , Nervio Oculomotor/patología , Factores de Edad , Animales , Animales Recién Nacidos , Axones/ultraestructura , Recuento de Células , Modelos Animales de Enfermedad , Embrión de Mamíferos , Enfermedades Hereditarias del Ojo/patología , Enfermedades Hereditarias del Ojo/fisiopatología , Movimientos Oculares/genética , Movimientos Oculares/fisiología , Fibrosis/patología , Fibrosis/fisiopatología , Regulación de la Expresión Génica/genética , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Células HEK293 , Humanos , Ratones , Ratones Transgénicos , Proteínas Asociadas a Microtúbulos/genética , Proteínas Asociadas a Microtúbulos/fisiología , Vías Nerviosas/metabolismo , Vías Nerviosas/patología , Vías Nerviosas/ultraestructura , Trastornos de la Motilidad Ocular/patología , Trastornos de la Motilidad Ocular/fisiopatología , Nervio Oculomotor/ultraestructura
6.
Curr Opin Neurobiol ; 22(5): 837-43, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22398400

RESUMEN

Axon pathfinding is essential for the establishment of proper neuronal connections during development. Advances in neuroimaging and genomic technologies, coupled with animal modeling, are leading to the identification of an increasing number of human disorders that result from aberrant axonal wiring. In this review, we summarize the recent clinical, genetic and molecular advances with regard to three human disorders of axon guidance: Horizontal gaze palsy with progressive scoliosis, Congenital mirror movements, and Congenital fibrosis of the extraocular muscles, Type III.


Asunto(s)
Axones/fisiología , Enfermedades de los Nervios Craneales/patología , Oftalmoplejía/patología , Escoliosis/patología , Animales , Axones/patología , Enfermedades de los Nervios Craneales/genética , Receptor DCC , Modelos Animales de Enfermedad , Humanos , Oftalmoplejía/genética , Receptores de Superficie Celular/genética , Receptores Inmunológicos/genética , Escoliosis/genética , Tubulina (Proteína)/genética , Proteínas Supresoras de Tumor/genética
7.
Cytoskeleton (Hoboken) ; 67(1): 32-42, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19743471

RESUMEN

The function and mechanism of macropinocytosis in cells outside of the immune system remain poorly understood. We used a neuroblastoma cell line, Neuro-2a, to study macropinocytosis in neuronal cells. We found that phorbol 12-myristate 13-acetate (PMA) and insulin-like growth factor 1 (IGF-1) induced two distinct types of macropinocytosis in the Neuro-2a cells. IGF-1-induced macropinocytosis occurs mostly around the cell bodies and requires phosphoinositide 3-kinase (PI3K), while PMA-induced macropinocytosis occurs predominantly in the neurites and is independent of PI3K activity. Both types of macropinocytosis were inhibited by a specific inhibitor of nonmuscle myosin II, blebbistatin. siRNA knockdown of nonmuscle myosin II isoforms, -IIA and -IIB, resulted in opposite effects on macropinocytosis induced by PMA or IGF. Myosin IIA knockdown significantly increased, whereas myosin IIB knockdown significantly decreased, macropinocytosis with correlating changes in membrane ruffle formation.


Asunto(s)
Miosina Tipo IIB no Muscular/metabolismo , Animales , Western Blotting , Línea Celular Tumoral , Técnica del Anticuerpo Fluorescente , Compuestos Heterocíclicos de 4 o más Anillos/farmacología , Factor I del Crecimiento Similar a la Insulina/farmacología , Ratones , Miosina Tipo IIB no Muscular/antagonistas & inhibidores , Miosina Tipo IIB no Muscular/genética , Pinocitosis/efectos de los fármacos , Ácidos Polimetacrílicos/farmacología , Isoformas de Proteínas/antagonistas & inhibidores , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA